nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—HTR3A—enteric nervous system—Parkinson's disease	0.0896	0.222	CbGeAlD
Rocuronium—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0679	0.168	CbGeAlD
Rocuronium—CHRNA1—tongue—Parkinson's disease	0.0291	0.0722	CbGeAlD
Rocuronium—HTR3A—nerve—Parkinson's disease	0.0177	0.0438	CbGeAlD
Rocuronium—CHRND—cardiovascular system—Parkinson's disease	0.0125	0.031	CbGeAlD
Rocuronium—CHRNA2—forebrain—Parkinson's disease	0.0103	0.0254	CbGeAlD
Rocuronium—HTR3A—brainstem—Parkinson's disease	0.00759	0.0188	CbGeAlD
Rocuronium—HTR3A—forebrain—Parkinson's disease	0.00733	0.0181	CbGeAlD
Rocuronium—CHRNA1—head—Parkinson's disease	0.00708	0.0175	CbGeAlD
Rocuronium—CHRNB1—medulla oblongata—Parkinson's disease	0.00689	0.0171	CbGeAlD
Rocuronium—CHRNB1—midbrain—Parkinson's disease	0.0063	0.0156	CbGeAlD
Rocuronium—CHRNB1—spinal cord—Parkinson's disease	0.00615	0.0152	CbGeAlD
Rocuronium—CHRM2—forebrain—Parkinson's disease	0.00612	0.0151	CbGeAlD
Rocuronium—SLC22A1—forebrain—Parkinson's disease	0.00601	0.0149	CbGeAlD
Rocuronium—CHRNA2—head—Parkinson's disease	0.00587	0.0145	CbGeAlD
Rocuronium—SLCO1A2—forebrain—Parkinson's disease	0.00578	0.0143	CbGeAlD
Rocuronium—CHRNA2—nervous system—Parkinson's disease	0.00557	0.0138	CbGeAlD
Rocuronium—CHRNB1—head—Parkinson's disease	0.00546	0.0135	CbGeAlD
Rocuronium—CHRNA2—central nervous system—Parkinson's disease	0.00536	0.0133	CbGeAlD
Rocuronium—CHRNA2—cerebellum—Parkinson's disease	0.00524	0.013	CbGeAlD
Rocuronium—CHRM2—cardiovascular system—Parkinson's disease	0.00517	0.0128	CbGeAlD
Rocuronium—CHRNA1—brain—Parkinson's disease	0.00513	0.0127	CbGeAlD
Rocuronium—CHRNB1—cerebellum—Parkinson's disease	0.00487	0.0121	CbGeAlD
Rocuronium—CHRNA2—brain—Parkinson's disease	0.00425	0.0105	CbGeAlD
Rocuronium—HTR3A—head—Parkinson's disease	0.0042	0.0104	CbGeAlD
Rocuronium—SLCO1A2—medulla oblongata—Parkinson's disease	0.00418	0.0103	CbGeAlD
Rocuronium—HTR3A—nervous system—Parkinson's disease	0.00398	0.00985	CbGeAlD
Rocuronium—CHRNB1—brain—Parkinson's disease	0.00396	0.0098	CbGeAlD
Rocuronium—HTR3A—central nervous system—Parkinson's disease	0.00383	0.00949	CbGeAlD
Rocuronium—SLCO1A2—midbrain—Parkinson's disease	0.00382	0.00946	CbGeAlD
Rocuronium—SLCO1A2—spinal cord—Parkinson's disease	0.00373	0.00923	CbGeAlD
Rocuronium—CHRM2—head—Parkinson's disease	0.0035	0.00867	CbGeAlD
Rocuronium—SLC22A1—head—Parkinson's disease	0.00344	0.00852	CbGeAlD
Rocuronium—CHRM2—nervous system—Parkinson's disease	0.00332	0.00822	CbGeAlD
Rocuronium—SLCO1A2—head—Parkinson's disease	0.00331	0.0082	CbGeAlD
Rocuronium—SLC22A1—nervous system—Parkinson's disease	0.00326	0.00808	CbGeAlD
Rocuronium—CHRM2—central nervous system—Parkinson's disease	0.0032	0.00792	CbGeAlD
Rocuronium—SLCO1A2—nervous system—Parkinson's disease	0.00314	0.00778	CbGeAlD
Rocuronium—SLC22A1—central nervous system—Parkinson's disease	0.00314	0.00778	CbGeAlD
Rocuronium—HTR3A—brain—Parkinson's disease	0.00304	0.00753	CbGeAlD
Rocuronium—SLCO1A2—central nervous system—Parkinson's disease	0.00302	0.00749	CbGeAlD
Rocuronium—SLCO1A2—cerebellum—Parkinson's disease	0.00295	0.00732	CbGeAlD
Rocuronium—CHRM2—brain—Parkinson's disease	0.00254	0.00628	CbGeAlD
Rocuronium—SLC22A1—brain—Parkinson's disease	0.00249	0.00617	CbGeAlD
Rocuronium—SLCO1A2—brain—Parkinson's disease	0.0024	0.00594	CbGeAlD
Rocuronium—Vecuronium—ABCB1—Parkinson's disease	0.00194	1	CrCbGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.001	0.00169	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—DLG4—Parkinson's disease	0.000994	0.00167	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—DLG1—Parkinson's disease	0.000988	0.00166	CbGpPWpGaD
Rocuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000972	0.00164	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—GRIN2B—Parkinson's disease	0.000971	0.00163	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—SLC6A3—Parkinson's disease	0.000957	0.00161	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—COMT—Parkinson's disease	0.000957	0.00161	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—MAOA—Parkinson's disease	0.00095	0.0016	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—DLG4—Parkinson's disease	0.000944	0.00159	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000923	0.00155	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—GRIN2B—Parkinson's disease	0.000923	0.00155	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—HTR7—Parkinson's disease	0.00092	0.00155	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—SLC6A3—Parkinson's disease	0.000909	0.00153	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000884	0.00149	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000884	0.00149	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.000871	0.00147	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000858	0.00144	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000856	0.00144	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000849	0.00143	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000849	0.00143	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000831	0.0014	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—COMT—Parkinson's disease	0.000814	0.00137	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—PENK—Parkinson's disease	0.000812	0.00137	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—MAOA—Parkinson's disease	0.000808	0.00136	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00079	0.00133	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000782	0.00132	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIK1—Parkinson's disease	0.000773	0.0013	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—COMT—Parkinson's disease	0.000773	0.0013	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—MAOA—Parkinson's disease	0.000768	0.00129	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GPR37—Parkinson's disease	0.000763	0.00128	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000742	0.00125	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000734	0.00124	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000707	0.00119	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000696	0.00117	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000674	0.00113	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000673	0.00113	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000671	0.00113	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000658	0.00111	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIK2—Parkinson's disease	0.000658	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000645	0.00109	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000645	0.00109	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000645	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—HTR2A—Parkinson's disease	0.000644	0.00108	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC18A2—Parkinson's disease	0.000637	0.00107	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00062	0.00104	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000608	0.00102	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000605	0.00102	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000603	0.00101	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00059	0.000993	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000566	0.000952	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000557	0.000937	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000553	0.000931	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000545	0.000917	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000545	0.000916	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000535	0.0009	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.000518	0.000872	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000514	0.000864	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000509	0.000857	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CHRNA4—Parkinson's disease	0.000504	0.000848	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000496	0.000834	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000493	0.00083	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.000491	0.000827	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000488	0.000821	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000476	0.000801	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000473	0.000795	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000469	0.000789	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000467	0.000785	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000465	0.000782	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ND3—Parkinson's disease	0.000464	0.000781	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MCCC1—Parkinson's disease	0.000464	0.000781	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000463	0.00078	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—HSPA8—Parkinson's disease	0.000462	0.000778	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00046	0.000774	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000456	0.000768	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.000449	0.000756	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000446	0.000751	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000442	0.000744	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000442	0.000744	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00044	0.00074	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TALDO1—Parkinson's disease	0.000437	0.000735	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—OMD—Parkinson's disease	0.000437	0.000735	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—DLG4—Parkinson's disease	0.000434	0.00073	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000431	0.000726	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000431	0.000725	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000431	0.000725	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIN2B—Parkinson's disease	0.000424	0.000713	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000419	0.000704	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.000418	0.000703	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC6A3—Parkinson's disease	0.000418	0.000703	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NDUFB11—Parkinson's disease	0.000414	0.000696	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000405	0.000681	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.0004	0.000673	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.0004	0.000673	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000399	0.000671	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GCH1—Parkinson's disease	0.000395	0.000664	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000394	0.000663	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000391	0.000659	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000391	0.000659	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000391	0.000658	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000379	0.000637	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000358	0.000602	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000356	0.000599	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000355	0.000598	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—COMT—Parkinson's disease	0.000355	0.000598	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—MAOA—Parkinson's disease	0.000353	0.000593	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GBA—Parkinson's disease	0.000352	0.000592	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—FBP1—Parkinson's disease	0.000352	0.000592	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—DBH—Parkinson's disease	0.000352	0.000592	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000342	0.000576	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000342	0.000576	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000342	0.000576	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MCCC1—Parkinson's disease	0.000339	0.000571	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ND3—Parkinson's disease	0.000339	0.000571	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000327	0.00055	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—OMD—Parkinson's disease	0.000319	0.000537	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TALDO1—Parkinson's disease	0.000319	0.000537	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000315	0.00053	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000308	0.000519	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000307	0.000517	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000304	0.000511	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	0.000302	0.000509	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.000298	0.000501	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000297	0.000499	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000295	0.000497	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000293	0.000493	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000288	0.000485	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCH1—Parkinson's disease	0.000288	0.000485	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00028	0.000471	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.000279	0.000469	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.000278	0.000467	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000274	0.000461	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000266	0.000448	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000261	0.000439	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000261	0.000439	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—DDC—Parkinson's disease	0.000258	0.000435	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—DBH—Parkinson's disease	0.000257	0.000432	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GBA—Parkinson's disease	0.000257	0.000432	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—FBP1—Parkinson's disease	0.000257	0.000432	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000257	0.000432	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000254	0.000427	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.000252	0.000424	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000248	0.000418	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000248	0.000417	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000246	0.000414	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTA4—Parkinson's disease	0.000244	0.00041	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000241	0.000405	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00024	0.000404	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000236	0.000397	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.000231	0.000389	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.000231	0.000389	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.000231	0.000388	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000225	0.000378	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLA2G6—Parkinson's disease	0.00022	0.00037	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MAOB—Parkinson's disease	0.000217	0.000366	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000216	0.000363	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.000214	0.000361	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000211	0.000356	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000209	0.000351	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000207	0.000348	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000201	0.000338	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—DDC—Parkinson's disease	0.000189	0.000317	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000187	0.000315	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000185	0.000311	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000183	0.000307	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000182	0.000307	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00018	0.000303	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00018	0.000303	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTA4—Parkinson's disease	0.000178	0.0003	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000175	0.000295	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000174	0.000293	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000172	0.000289	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000168	0.000283	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000163	0.000274	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	0.000162	0.000272	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	0.00016	0.00027	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MAOB—Parkinson's disease	0.000159	0.000267	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CTGF—Parkinson's disease	0.000159	0.000267	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000158	0.000266	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000157	0.000264	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000156	0.000262	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000153	0.000257	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000152	0.000256	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000149	0.000251	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000149	0.000251	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000148	0.000249	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	0.000148	0.000249	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000147	0.000248	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000147	0.000248	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NQO1—Parkinson's disease	0.000146	0.000246	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000145	0.000244	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TH—Parkinson's disease	0.000144	0.000242	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYCS—Parkinson's disease	0.000138	0.000233	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000138	0.000233	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000136	0.000229	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000134	0.000225	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000134	0.000225	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000128	0.000216	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000127	0.000213	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—COMT—Parkinson's disease	0.000122	0.000206	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	0.000122	0.000205	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MAOA—Parkinson's disease	0.000122	0.000205	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	0.00012	0.000202	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	0.000118	0.000199	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000118	0.000199	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CTGF—Parkinson's disease	0.000116	0.000195	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	0.000115	0.000194	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	0.000112	0.000188	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000111	0.000187	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	0.000108	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000108	0.000181	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GPX1—Parkinson's disease	0.000107	0.00018	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000107	0.00018	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NQO1—Parkinson's disease	0.000107	0.00018	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TH—Parkinson's disease	0.000105	0.000177	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000103	0.000174	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYCS—Parkinson's disease	0.000101	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INSR—Parkinson's disease	9.94e-05	0.000167	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	9.9e-05	0.000167	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGB—Parkinson's disease	9.39e-05	0.000158	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	9.37e-05	0.000158	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	9.35e-05	0.000157	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOE—Parkinson's disease	9.21e-05	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	9.2e-05	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	9.03e-05	0.000152	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—COMT—Parkinson's disease	8.94e-05	0.00015	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—Parkinson's disease	8.9e-05	0.00015	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MAOA—Parkinson's disease	8.88e-05	0.000149	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—Parkinson's disease	8.78e-05	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	8.74e-05	0.000147	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—Parkinson's disease	8.43e-05	0.000142	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—Parkinson's disease	8.18e-05	0.000138	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	8.16e-05	0.000137	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	7.91e-05	0.000133	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	7.91e-05	0.000133	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—INS—Parkinson's disease	7.87e-05	0.000132	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GPX1—Parkinson's disease	7.83e-05	0.000132	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—Parkinson's disease	7.23e-05	0.000122	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOE—Parkinson's disease	6.73e-05	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	6.62e-05	0.000111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	6.41e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	6.33e-05	0.000107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NGF—Parkinson's disease	5.82e-05	9.79e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—INS—Parkinson's disease	5.75e-05	9.67e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	5.54e-05	9.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOE—Parkinson's disease	5.15e-05	8.66e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INS—Parkinson's disease	4.4e-05	7.4e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	3.27e-05	5.51e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	3.25e-05	5.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	3.01e-05	5.06e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.92e-05	3.23e-05	CbGpPWpGaD
